Source comparison
Melanotan I vs Melanotan II: Comparative Melanocortin Receptor Pharmacology Research
Melanotan I vs Melanotan II: Comparative Melanocortin Receptor Pharmacology Research Melanotan peptides represent synthetic analogs of α-melanocyte stimulating hormone (α-MSH) extensively studied in cell-based assay formats for their melanocortin receptor bind
This comparison does not assign a generated winner or score.
- Melanotan I vs Melanotan II: Comparative Melanocortin Receptor Pharmacology Research
- Melanotan peptides represent synthetic analogs of α-melanocyte stimulating hormone (α-MSH) extensively studied in cell-based assay formats for their melanocortin receptor binding properties. Published in vitro research characterizes their molecular interactions, binding affinity profiles, and downstream pathway engagement in defined cell model systems under controlled laboratory conditions. These peptides demonstrate distinct pharmacological profiles across melanocortin receptor subtypes, making them valuable research tools for investigating melanocortin signaling pathways.
- Receptor Pharmacology and Mechanism of Action
- Melanotan I (Afamelanotide) Receptor Profile
- Melanotan I exhibits selective binding affinity for melanocortin-1 receptor (MC1R) with documented EC50 values ranging from 0.1-1.0 nM in transfected cell models. In vitro assays demonstrate high specificity for MC1R compared to other melanocortin receptor subtypes. The peptide demonstrates competitive binding characteristics in radioligand displacement studies, effectively competing with endogenous α-MSH for receptor occupancy.
- Cell-based cAMP accumulation assays reveal potent adenylyl cyclase activation following MC1R binding. Melanotan I demonstrates full agonist activity with maximal cAMP responses reaching 85-95% of forskolin-stimulated levels in MC1R-expressing cell lines. The peptide exhibits a steep dose-response curve characteristic of high-affinity receptor interactions.
- Melanotan II Pan-Melanocortin Activity
- Melanotan II demonstrates broader melanocortin receptor pharmacology with significant binding affinity across MC1R, MC3R, MC4R, and MC5R subtypes. In vitro binding studies reveal EC50 values of 0.3 nM (MC1R), 2.1 nM (MC3R), 1.1 nM (MC4R), and 2.8 nM (MC5R) in respective transfected cell models. This pan-melanocortin activity distinguishes Melanotan II from the MC1R-selective profile of Melanotan I.
- Functional assays demonstrate robust cAMP signaling activation across multiple receptor subtypes. MC4R-expressing cell lines show particularly strong responses to Melanotan II stimulation, with cAMP accumulation reaching maximal levels at nanomolar concentrations. G-protein coupling efficiency studies indicate optimal Gs-adenylyl cyclase pathway activation across the melanocortin receptor family.
- Comparative Binding Kinetics and Signaling Pathways
- Binding Affinity Analysis
- Competitive binding assays reveal distinct kinetic profiles between Melanotan peptides. Melanotan I demonstrates slower association rates (kon = 2.1 × 10^6 M^-1s^-1) but significantly slower dissociation kinetics (koff = 0.08 s^-1) at MC1R, resulting in extended receptor occupancy duration. Surface plasmon resonance studies confirm high-affinity binding with KD values consistently below 1 nM.
- Melanotan II exhibits faster association kinetics across melanocortin receptors but demonstrates more rapid dissociation rates. MC4R binding studies show kon values of 4.2 × 10^6 M^-1s^-1 with koff rates of 0.15 s^-1, indicating dynamic receptor interactions with moderate residence times.
- Downstream Signaling Cascade Activation
- Both peptides activate canonical melanocortin signaling through Gs-coupled receptor mechanisms. Forskolin-adenylyl cyclase assays demonstrate robust cAMP elevation following peptide treatment in melanocortin receptor-expressing cell models. Secondary messenger quantification reveals peak cAMP concentrations occurring 15-30 minutes post-stimulation.
- Protein kinase A (PKA) activation studies show differential signaling intensity between peptides. Melanotan II demonstrates broader PKA substrate phosphorylation patterns correlating with its pan-melanocortin activity profile. Western blot analysis reveals enhanced CREB phosphorylation in MC4R-expressing cells treated with Melanotan II compared to Melanotan I.
- Enzyme Kinetics and Metabolic Stability
- Proteolytic Resistance Profiles
- In vitro stability assays using physiological protease panels reveal enhanced metabolic resistance for both peptides compared to endogenous α-MSH. Melanotan I demonstrates superior stability in serum-containing media with T1/2 values exceeding 4 hours under standard cell culture conditions. HPLC-MS analysis confirms minimal degradation products formation during extended incubation periods.
- Melanotan II shows moderate proteolytic resistance with detectable degradation occurring after 2-3 hours in serum-containing assay buffers. Peptidase sensitivity studies identify primary cleavage sites at C-terminal regions, though overall stability remains significantly enhanced versus native melanocortin peptides.
- Research Summary
- Comparative analysis of Melanotan I and Melanotan II reveals distinct receptor pharmacology profiles suitable for different research applications. Melanotan I demonstrates selective MC1R targeting with extended receptor residence times, making it optimal for MC1R-specific pathway investigations. Melanotan II provides broader melanocortin receptor coverage with particular utility for MC4R signaling studies. Both peptides exhibit enhanced metabolic stability and potent cAMP signaling activation, establishing them as valuable research tools for melanocortin receptor pharmacology investigations in controlled in vitro experimental systems.
- All content is intended for in vitro laboratory research purposes only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any condition.
- Hexarelin
- TB-500
- Epithalon
- Ipamorelin
- Tirzepatide
- CJC-1295 DAC
- PT-141
- Semaglutide
- Selank
- BPC-157
- Sermorelin
- Melanotan 2
- IGF LR3
- Tesamorelin
- AICAR
- IGF-DES
- GHRP 2
- Albuterol
- Tamoxifen
- Letrozole
- Clomiphene
- Tadalafil
- Clenbuterol
- Anastrozole
- Finasteride
- Exemestane
- Sildenafil
- Yohimbine
- Bacteriostatic Water Recent Posts Melanotan 2 (MT2): Mechanism, Research, and Safety Considerations Ipamorelin: The Selective GHRP, Explained Tesamorelin: The GHRH Analog Studied for Visceral Fat Sermorelin: The Original GHRH Analog, Explained CJC-1295: How the GHRH Analog Works, and What Research Shows
- Already a customer? Sign In
- Create Account
- All products on this site are for Research, Development use only. Products are Not for Human consumption of any kind. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.
- ElementSarms is a chemical supplier. ElementSarms is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. ElementSarms is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.
- Sarms
- Stacks
- Research Liquids
- Albuterol 5MG/ML | 30ML with dropper
- Anastrozole 1.5MG/ML | 30ML with dropper
- Clomiphene 50MG/ML | 30ML with dropper
- Finasteride 5MG/ML | 30ML with dropper
- Letrozole 3.5 MG/ML | 30ML with dropper
- LiquiCia 30MG/ML | 30ML with dropper
- LiquiCia T50 50MG/ML | 30ML with dropper
- LiquiClen 200MCG/ML | 30ML with dropper
- Liquistane / Exemestane 25MG/ML | 30ML with dropper
- LiquiTamo 20MG/ML | 30ML with dropper
- LiquiVia 25MG/ML | 30 ML with dropper
- T3 LIOTHYRONINE 200MCG/ML | 30ML with dropper
- Toremifene Citrate 60MG/ML | 30ML with dropper
- Yohimbine HCL 10MG/ML | 30ML with dropper
- Research Peptides
- Aicar 50MG
- BPC-157 + TB-500 Blend 2mg ea/ 4MG
- BPC-157 5MG
- CJC-1295 + DAC 2MG
- CJC-1295 | No DAC 2MG
- Epithalon 10MG
- Frag Premium 176-191 5MG
- GHK-CU Copper Peptide 50MG
- GHRP-2 5MG
- GHRP-6 5MG
- Hexarelin 5MG
- IGF-1 DES 1MG
- IGF-1 LR3 1MG
- Ipamorelin 5MG
- Melanotan 2 10MG
- NAD+ 500MG
- PT-141 / Bremelanotide 10MG
- GLP-1/GIP/GCG (RT)
- Selank 5MG
- GLP1 (SM)
- Sermorelin 5MG
- TB-500 5MG
- GIP/GLP-1 (TZ)
- PDE5 Inhibitors
- GLP-1
- Diluents
- Bacteriostatic Water 10ML